Cargando…

A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases

When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.

Detalles Bibliográficos
Autores principales: Nakamura, Naohiko, Kinami, Shinichi, Fujii, Yoritaka, Miura, Seiko, Fujita, Jun, Kaida, Daisuke, Tomita, Yasuto, Miyata, Takashi, Fujita, Hideto, Ueda, Nobuhiko, Kosaka, Takeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452495/
https://www.ncbi.nlm.nih.gov/pubmed/30997070
http://dx.doi.org/10.1002/ccr3.2056
_version_ 1783409300020920320
author Nakamura, Naohiko
Kinami, Shinichi
Fujii, Yoritaka
Miura, Seiko
Fujita, Jun
Kaida, Daisuke
Tomita, Yasuto
Miyata, Takashi
Fujita, Hideto
Ueda, Nobuhiko
Kosaka, Takeo
author_facet Nakamura, Naohiko
Kinami, Shinichi
Fujii, Yoritaka
Miura, Seiko
Fujita, Jun
Kaida, Daisuke
Tomita, Yasuto
Miyata, Takashi
Fujita, Hideto
Ueda, Nobuhiko
Kosaka, Takeo
author_sort Nakamura, Naohiko
collection PubMed
description When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.
format Online
Article
Text
id pubmed-6452495
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64524952019-04-17 A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases Nakamura, Naohiko Kinami, Shinichi Fujii, Yoritaka Miura, Seiko Fujita, Jun Kaida, Daisuke Tomita, Yasuto Miyata, Takashi Fujita, Hideto Ueda, Nobuhiko Kosaka, Takeo Clin Case Rep Case Reports When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients. John Wiley and Sons Inc. 2019-02-26 /pmc/articles/PMC6452495/ /pubmed/30997070 http://dx.doi.org/10.1002/ccr3.2056 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Nakamura, Naohiko
Kinami, Shinichi
Fujii, Yoritaka
Miura, Seiko
Fujita, Jun
Kaida, Daisuke
Tomita, Yasuto
Miyata, Takashi
Fujita, Hideto
Ueda, Nobuhiko
Kosaka, Takeo
A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_full A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_fullStr A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_full_unstemmed A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_short A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_sort remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: a report of two cases
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452495/
https://www.ncbi.nlm.nih.gov/pubmed/30997070
http://dx.doi.org/10.1002/ccr3.2056
work_keys_str_mv AT nakamuranaohiko aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT kinamishinichi aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT fujiiyoritaka aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT miuraseiko aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT fujitajun aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT kaidadaisuke aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT tomitayasuto aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT miyatatakashi aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT fujitahideto aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT uedanobuhiko aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT kosakatakeo aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT nakamuranaohiko remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT kinamishinichi remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT fujiiyoritaka remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT miuraseiko remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT fujitajun remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT kaidadaisuke remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT tomitayasuto remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT miyatatakashi remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT fujitahideto remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT uedanobuhiko remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT kosakatakeo remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases